<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Nimodipine was given as an intracarotid slow bolus injection in six patients with <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) due to rupture of a <z:hpo ids='HP_0004944'>cerebral aneurysm</z:hpo>, with angiographically demonstrated vasospasm </plain></SENT>
<SENT sid="1" pm="."><plain>The patients were followed by serial angiograms for demonstration of the effect of nimodipine on vasospasm </plain></SENT>
<SENT sid="2" pm="."><plain>After angiography, <z:hpo ids='HP_0000001'>all</z:hpo> patients were treated with a constant venous infusion of this new calcium <z:chebi fb="68" ids="48706">antagonist</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Although the therapeutic regimen was started only a few hours after <z:hpo ids='HP_0003674'>onset</z:hpo> of vasospasm, there was no change in cerebral vessel caliber detectable on angiograms following the intracarotid injection </plain></SENT>
<SENT sid="4" pm="."><plain>Three patients died, two patients finally recovered with neurological deficits due to <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, and one patient with asymptomatic vasospasm remained symptom-free </plain></SENT>
<SENT sid="5" pm="."><plain>Although nimodipine may act to prevent <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after SAH, the authors believe that the intracarotid application is not effective after vasospasm has occurred </plain></SENT>
</text></document>